Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis

Published:2019-11-15 Issue:22 Volume:58 Page:3323-3329
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Nishigori Ryusei¹²,Warabi Yoko¹,Shishido-Hara Yukiko³⁴,Nakamichi Kazuo⁵,Nakata Yasuhiro⁶,Komori Takashi⁷,Isozaki Eiji¹

Affiliation:

1. Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan

2. Department of Neurology, Kyoto University Graduate School of Medicine, Japan

3. Department of Anatomic Pathology, Tokyo Medical University, Japan

4. Department of Pathology and Applied Neurobiology, Kyoto Prefectural University of Medicine, Japan

5. Department of Virology 1, National Institute of Infectious Diseases, Japan

6. Department of Neuroradiology, Tokyo Metropolitan Neurological Hospital, Japan

7. Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/22/58_3038-19/_pdf

Reference15 articles.

1. 1. Berger JR, Cree BA, Greenberg B, et al. Progressive multifocal leukoencephalopathy after fingolimod treatment. Neurology 90: e1815-e1821, 2018.

2. 2. Nishiyama S, Misu T, Shishido-Hara Y, et al. Fingolimod-associated PML with mild IRIS in MS: a clinicopathologic study. Neurol Neuroimmunol Neuroinflamm 5: e415, 2018.

3. 3. Ishii J, Shishido-Hara Y, Kawamoto M, et al. A punctate magnetic resonance imaging pattern in a patient with systemic lupus erythematosus is an early sign of progressive multifocal leukoencephalopathy: a clinicopathological study. Intern Med 57: 2727-2734, 2018.

4. 4. Wattjes MP, Wijburg MT, Vennegoor A, et al. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. J Neurol Neurosurg Psychiatry 87: 879-884, 2016.

5. 5. Metz I, Radue EW, Oterino A, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123: 235-245, 2012.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory progressive multifocal leukoencephalopathy with human T-cell lymphotropic virus-1 coinfection;BMJ Case Reports;2024-04

2. A case of progressive multifocal leukoencephalopathy in a post-kidney transplant patient with improvement after discontinuation of immunosuppressive drugs and combination therapy with mefloquine and mirtazapine;Renal Replacement Therapy;2023-12-19

3. Pathology for severe inflammatory PML with PD1/PD‐L1 expression of favorable prognosis: What's a prognostic factor for PML‐IRIS?;Neuropathology;2023-07-09

4. Tofacitinib-induced Progressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome;Clinical Neurology and Neurosurgery;2022-03

5. Roles of CD3, CD4 and CD8 in synovial lymphocytes of rheumatoid arthritis;Polish Journal of Pathology;2022